What Researchers Did
Researchers described the treatment of three patients with emphysematous cholecystitis, including hyperbaric oxygen therapy.
What They Found
The study highlighted three specific cases of emphysematous cholecystitis where hyperbaric oxygenation was used. In these three instances, hyperbaric oxygen therapy was considered an excellent additional therapy alongside urgent surgery or intensive non-surgical treatments.
What This Means for Canadian Patients
For Canadian patients diagnosed with severe emphysematous cholecystitis, this report suggests that hyperbaric oxygen therapy might be a valuable addition to standard treatments like surgery. It indicates a potential benefit for managing this serious infection, especially when conventional approaches are also used.
Canadian Relevance
Although this study did not involve Canadian authors or institutions, it covers a condition related to gas gangrene, which is a Health Canada-recognized indication for hyperbaric oxygen therapy. Emphysematous cholecystitis involves gas-forming bacteria, similar to other severe infections where hyperbaric oxygen therapy is used.
Study Limitations
As a case report involving only three patients, this study provides limited evidence and does not include a control group for comparison.